MDM2 and idiopathic pulmonary arterial hypertension: MDM2 also promotes tissue inflammation by regulating mitochondrial damage, and MDM2 inhibitors have effective anti-inflammatory effects both in vitro and in vivo.[21,22] These findings nominate MDM2 as a novel factor in IPAH, prompting further investigation to define its mechanistic and therapeutic roles.